AVENUE THERAPEUTICS, INC.
OTC · CIK 0001644963 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-714,000
Net Income
$-695,000
Eps Basic
-0.21
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-714,000 | - | - |
| Net Income | $-695,000 | - | - |
| Eps Basic | -0.21 | - | - |
| Cash And Equivalents | $2.4M | - | - |
| Total Assets | $2.5M | - | - |
| Total Liabilities | $1.3M | - | - |
| Shareholders Equity | $1.2M | - | - |
| Operating Cash Flow | $-438,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | AVENUE THERAPEUTICS, INC. | 2026-05-08 | 0001437749-26-015759 |
| 10-K | AVENUE THERAPEUTICS, INC. | 2026-03-30 | 0001437749-26-010359 |
| 4 | AVENUE THERAPEUTICS, INC. | 2026-01-06 | 0001429260-26-000004 |
| 10-Q | AVENUE THERAPEUTICS, INC. | 2025-11-13 | 0001437749-25-034821 |
| 10-Q | AVENUE THERAPEUTICS, INC. | 2025-08-14 | 0001437749-25-026935 |